Reported Dosage Regimens (Not Clinically Approved): Daily: 1ml injection Twice Weekly: 1.5ml injection Crucial Note: These dosage examples are based on user reports, not clinical trials
After 68 weeks, patients in the semaglutide group lost an average of 15% of their baseline body weight, or 33.7 pounds, compared to 2.4%, or 5.7 pounds, in the placebo group
(More information) Presently, there is little evidence that supplementation with B vitamins, antioxidant vitamins, choline, or omega-3 fatty acids will improve memory performance
The documentation requirements are the same: prescription, LMN (when required), and itemized receipts
However, labeling does not currently permit use of Wegovy for those with heart failure
time-to-plateau lengthens with dose